AI-powered kidney disease and transplant management diagnostic developer RenalytixAI said yesterday that it received an FDA breakthrough device designation for its KidneyIntelX artificial-intelligence powered diagnostic for kidney disease. The New York-based company touted the FDA clearance as the first ever for an AI-powered kidney disease diagnostic. The KidneyIntelX is designed to diagnose and improve clinical management of […]
renalytixai
Renal diagnostic dev RenalytixAI closes $29m IPO
AI-powered kidney disease and transplant management diagnostic developer RenalytixAI said this week it completed an $29 million initial public offering on the London Stock Exchange’s Alternative Investment Market. The company was formed through an exclusive license with Mount Sinai Health Systems, who also acted as a development collaborator. The groups have been collaborating since May […]